Kashyap Patel, MD, CEO of Carolina Blood and Cancer Care Associates, and current president of the Community Oncology Alliance (COA), speaks on what he’s looking forward to for his first in-person Community Oncology Conference as COA president.
I’m looking forward to seeing attendees and taking part in live in-person discussions at the 2022 Community Oncology Conference, said Kashyap Patel, MD, CEO of Carolina Blood and Cancer Care Associates, and current president of the Community Oncology Alliance (COA)
Transcript
Entering your second year as president of COA and first year with the Community Oncology Conference in person, what should attendees look forward to at the upcoming meeting?
This is a very incredible year, because in the last 2 years we've seen so many challenges—a once in 100 years global public health emergency, and I felt I was almost going to be the virtual president for 2 years.
Now that things are opening up, I'll now be somebody who can touch, feel, and sense. I’m a people's person, so I'm looking forward to seeing people in person, hugging, touching, talking, and feeling like a human being. I'm telling you, 2 years have literally deprived us of our sense of being who we are as a human being, and I'm looking forward to really live exchange interactions—an in-person meeting to really make a difference in people's lives.
Global Status of HIV/AIDS Pandemic Takes Center Stage in Opening Session
March 10th 2025The Conference for Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about the progress, and lack of progress, has been made in the fight against the HIV pandemic given the current political climate.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Reviving the Classics: The Role of Older Medications in Modern Dermatology
March 9th 2025Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.
Read More
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More